Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 545403Erstellt: 24. Oktober 2026

((R)-1-Piperidin-4-yl-pyrrolidin-2-yl)-methanol di-hydrochloride → [2-(3-Hexyl-phenyl)-5-iodo-3-methyl-3H-imidazol-4-yl]-[4-((R)-2-hydroxymethyl-pyrrolidin-1-yl)-piperidin-1-yl]-methanone

https://huagongshe.com/de/reaction/545403

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt((R)-1-Piperidin-4-yl-pyrrolidin-2-yl)-methanol di-hydrochlorideHCID 67133026—
Edukt2-(3-Hexyl-phenyl)-5-iodo-3-methyl-3H-imidazole-4-carboxylic acidHCID 67133239—
Produkt[2-(3-Hexyl-phenyl)-5-iodo-3-methyl-3H-imidazol-4-yl]-[4-((R)-2-hydroxymethyl-pyrrolidin-1-yl)-piperidin-1-yl]-methanoneHCID 57541141—

Reaktionsschritte

In analogy to the procedure described for example 2, 2-(3-hexyl-phenyl)-5-iodo-3-methyl-3H-imidazole-4-carboxylic acid (intermediate 1) and ((R)-1-piperidin-4-yl-pyrrolidin-2-yl)-methanol di-hydrochloride (intermediate 2) gave the title compound as light red amorphous solid. MS: 579.3 (MH+).

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS07935707B2
Quelldatensatzuspto-grants-2011_05
ORD IDord-8644913ba96e4da29633a33912dcbc58
Quellennotizuspto-grants-2011_05